Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 265-0535

Ibrahim Nassour, MD, MSCS : Research

Cancer Specialist (Oncologist), Surgical Oncologist (Surgical Specialist - Cancer)

Additional languages:
Arabic,
French
Photo of Ibrahim Nassour
(352) 265-0535 MyUFHealth

Research at a glance

Top areas of exploration

  • Pancreatic Neoplasms , 19 publications
  • Adenocarcinoma , 15 publications
  • Pancreaticoduodenectomy , 12 publications
  • Postoperative Complications , 10 publications

Research activity

84 publications

1,198 citations

Why is this important?

Active clinical trials

My publications

84 publications

2024

Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Journal of surgical oncology

PubMed • Publisher's site

2023

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.

Future oncology (London, England)

PubMed • Publisher's site

2023

A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma

Pancreatology

PubMed • Publisher's site

2023

Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.

Oncotarget

PubMed • Publisher's site

2023

Appendectomy Is Oncologically Equivalent to Right Hemicolectomy for Well-Differentiated T1 Appendiceal Adenocarcinoma.

Diseases of the colon and rectum

PubMed • Publisher's site